NUZ

6.25%

22.5¢ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-757

First 757 Last

Share
Profile

Follow
Bugspray

319 Posts.

40

21/06/22

12:40

Post #: 62111752
Share

Originally posted by NZ Trader ↑

50 Days ago
Appendix 4C and Quarterly Update
29 April 2022 – Perth, Australia: PharmAust Limited (ASX: PAA & PAAO), a clinical stage biotechnology
company, is pleased to present its Appendix 4C and Quarterly Update for the period ended 31 March 2022.
HIGHLIGHTS:
• Completed manufacture of GMP-Grade Monepantel (MPL) for Human Clinical Trials

• Completed tablet manufacture and accelerated stability data pending

• Protocols and ethics/regulatory approvals are now in place for MND human trial

• Alithia Life Sciences appointed trial manager of MND human trial

• Patients are being recruited and commencement of the MND trial is expected in late May 2022

• PharmAust’s European CRO partner, Ergomed, has identified seven hospitals in five countries
showing interest in testing the effects of MPL upon COVID-19 patients

• PharmAust and WEHI investigating MPL in HTLV-1 viral infections

• WEHI demonstrated that MPL and MPLS can kill HTLV-1-transformed leukaemia cell lines and
inhibit HTLV-1 protein production

• Canine cancer trial indicates the combination of MPL + prednisolone more than doubles life
expectancy of dogs compared with standard-of-care

• PharmAust will seek input for the canine cancer registration (Phase 3) trial from potential
licensing partners

• Plans are to conduct the registration trial in canines with B-cell lymphoma in Australia, New
Zealand and the USA

• Dogs successfully recruited for canine trials in New Zealand

• Epichem completes WasteSorted e-Waste Grant from the WA state government

• Proof of concept work has been determined on Coal and Ligno-cellulosic Biomass

• Bank balance of approximately $2.14 million as at 31 March

Not a single announcement for June during the most financially turbulent month in a decade ..........

Expand

Disgraceful.... zero active preservation of shareholder value, and here we are at 7.7 cents......

How are the dogs in the USA doing?????
Even an update on that would no doubt assist in at the very least slowing the bleed!

With well over 1m shares in my portfolio, I feel somewhat in a position to be very dissatisfied.

BS

PAA Price at posting: 7.7¢ Sentiment: Buy Disclosure: Held
10 Upvote

3 Great analysis

Reply

Top Stories

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

There are more pages in this discussion • 710 more messages in this thread...

First 757 Last

Add NUZ (ASX) to my watchlist

(20min delay)
Last 22.5¢		Change -0.015(6.25%)		Mkt cap ! $109.4M

Open	High	Low	Value	Volume
24.0¢	24.0¢	22.5¢	$133.9K	573.8K

Buyers (Bids)

No.	Vol.	Price($)
3	303213	22.5¢

Sellers (Offers)

Price($)	Vol.	No.
23.0¢	57592	2

View Market Depth

No.	Vol.	Price($)
2	258769	0.225
9	351041	0.220
2	26627	0.215
1	10000	0.210
3	101948	0.205

Price($)	Vol.	No.
0.230	42000	1
0.240	20367	1
0.245	339236	4
0.250	306054	5
0.255	8641	1

Last trade - 15.46pm 18/10/2024 (20 minute delay)

NUZ (ASX) Chart

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-757

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Nanoveu surges 10% after benchmark testing for new AI chip begins

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

Macro, Norden set up transport solutions initiative for West Pilbara

Sierra Nevada raises $2M for silver exploration at Blackhawk

Talga Group wins key permit for flagship graphite mine in Sweden

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-757

Top Stories

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Nanoveu surges 10% after benchmark testing for new AI chip begins

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

Macro, Norden set up transport solutions initiative for West Pilbara

Sierra Nevada raises $2M for silver exploration at Blackhawk

Talga Group wins key permit for flagship graphite mine in Sweden

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News